Search Results 461-470 of 18346 for total bilirubin

1. Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer - Mayo Clinic

   Total Bilirubin ≤ 1.5 x ULN. Bilirubin for patients w/Gilbert's ≤ 3.0 x ULN. Calc. Creatinine Clearance > 20 ml/min (using either CKD-EP1 equation or ...

2. A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002) - Mayo Clinic

   Total bilirubin ≤ 1.5 X ULN 5. AST/ALT ≤ 3.0 X ULN (≤5 X ULN in case of hepatic metastasis) 6. Estimated creatinine clearance ≥ 30 mL/min based on ...

3. Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial - Mayo Clinic

   - Total Bilirubin =< 1.5 mg/dL (obtained =< 14 days prior to protocol randomization) - Aspartate aminotransferase (AST)(serum glutamic oxaloacetic transaminase

4. A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis. - Mayo Clinic

   ... total bilirubin more than 1.5 × ULN (unless due to Gilbert syndrome or non-liver-related disorder). * Acute liver disease, cirrhosis, chronic liver disease ...

5. Autoimmune hepatitis - Symptoms and causes - Mayo Clinic

   This type of hepatitis happens when the immune system attacks the liver with destructive antibodies. Immune-suppressing medicine is the main treatment.

6. Aspartate aminotransferase (AST) blood test - Mayo Clinic

   Serum glutamic-oxaloacetic transaminase test. SGOT test. Why it's done. An AST test is done to check for liver injury. It does not tell you how the liver is ...

7. A Study to Test the Addition of Nivolumab to Chemotherapy to Treat Soft Tissue Sarcoma - Mayo Clinic

   Total bilirubin ≤ 1.5 x upper limit of normal (ULN). For patients with documented/suspected Gilbert's disease, bilirubin ≤ 3 x ULN. Aspartate ...

8. Memantine Hydrochloride and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Reducing Neurocognitive Decline in Patients With Brain Metastases - Mayo Clinic

   Total bilirubin =< 2.5 mg/dL (43 umol/L); Patients may have had prior therapy for brain metastasis, including radiosurgery and surgical resection; patients ...

9. Sorafenib Tosylate With or Without Everolimus in Treating Patients With Advanced, Radioactive Iodine Refractory Hurthle Cell Thyroid Cancer - Mayo Clinic

   Total bilirubin ≤ 1.5 x upper limits of normal (ULN);; Serum glutamic oxaloacetic transaminase (SGOT) (AST) ≤ 2.5 x ULN;; Fasting serum cholesterol ≤ 300 mg/ ...

10. Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment - Mayo Clinic

    - Total bilirubin ≤ 2 x institutional upper limit of normal (ULN). - Aspartate aminotransferase (AST) serum glutamic oxaloacetic transaminase (SGOT)/ ...